Barclays’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,577
Closed -$10K 4223
2023
Q3
$10K Buy
+5,577
New +$10K ﹤0.01% 4021
2022
Q3
Sell
-164
Closed 4666
2022
Q2
$0 Sell
164
-6,530
-98% ﹤0.01% 4744
2022
Q1
$22K Sell
6,694
-43,357
-87% -$142K ﹤0.01% 4304
2021
Q4
$210K Buy
50,051
+32,885
+192% +$138K ﹤0.01% 2813
2021
Q3
$140K Buy
17,166
+11,221
+189% +$91.5K ﹤0.01% 3109
2021
Q2
$45K Sell
5,945
-28,399
-83% -$215K ﹤0.01% 3431
2021
Q1
$299K Buy
34,344
+21,084
+159% +$184K ﹤0.01% 2945
2020
Q4
$105K Sell
13,260
-5,540
-29% -$43.9K ﹤0.01% 2962
2020
Q3
$150K Sell
18,800
-10
-0.1% -$80 ﹤0.01% 2872
2020
Q2
$185K Buy
18,810
+8,698
+86% +$85.5K ﹤0.01% 2847
2020
Q1
$77K Sell
10,112
-20,509
-67% -$156K ﹤0.01% 2927
2019
Q4
$118K Buy
30,621
+15,453
+102% +$59.5K ﹤0.01% 3395
2019
Q3
$76K Sell
15,168
-4,572
-23% -$22.9K ﹤0.01% 3533
2019
Q2
$130K Sell
19,740
-1,265
-6% -$8.33K ﹤0.01% 3444
2019
Q1
$159K Buy
21,005
+7,415
+55% +$56.1K ﹤0.01% 3124
2018
Q4
$109K Buy
13,590
+1,517
+13% +$12.2K ﹤0.01% 2947
2018
Q3
$155K Buy
12,073
+9,768
+424% +$125K ﹤0.01% 3189
2018
Q2
$27K Sell
2,305
-5,217
-69% -$61.1K ﹤0.01% 3519
2018
Q1
$53K Sell
7,522
-25,670
-77% -$181K ﹤0.01% 3485
2017
Q4
$216K Buy
+33,192
New +$216K ﹤0.01% 2606
2017
Q3
Sell
-2
Closed 4017
2017
Q2
$0 Sell
2
-2,555
-100% ﹤0.01% 3893
2017
Q1
$11K Buy
2,557
+2,507
+5,014% +$10.8K ﹤0.01% 3506
2016
Q4
$0 Buy
50
+46
+1,150% ﹤0.01% 3841
2016
Q3
$0 Hold
4
﹤0.01% 3945
2016
Q2
$0 Buy
+4
New ﹤0.01% 3634
2015
Q3
Sell
-2,268
Closed -$14K 3970
2015
Q2
$14K Buy
+2,268
New +$14K ﹤0.01% 3126